Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin in Pediatric cSSSI
NCT00711802Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Jul 2008
- Primary completion
- Oct 2013
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of daptomycin in Skin and Skin Structure Infection (SSSI), sponsored by Merck & Co.. Started Jul 2008; status: completed.
02
Drugs
daptomycin
03
Conditions
Skin and Skin Structure Infection (SSSI)
Beyond the preview
Go deeper on NCT00711802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00711802.